These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27210751)

  • 1. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.
    Hamilton A; Vasefi M; Vander Tuin C; McQuaid RJ; Anisman H; Ferguson SS
    Cell Rep; 2016 May; 15(9):1859-65. PubMed ID: 27210751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy is increased following either pharmacological or genetic silencing of mGluR5 signaling in Alzheimer's disease mouse models.
    Abd-Elrahman KS; Hamilton A; Vasefi M; Ferguson SSG
    Mol Brain; 2018 Apr; 11(1):19. PubMed ID: 29631635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease.
    Hamilton A; Esseltine JL; DeVries RA; Cregan SP; Ferguson SS
    Mol Brain; 2014 May; 7():40. PubMed ID: 24886239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aβ oligomers induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner.
    Abd-Elrahman KS; Albaker A; de Souza JM; Ribeiro FM; Schlossmacher MG; Tiberi M; Hamilton A; Ferguson SSG
    Sci Signal; 2020 Dec; 13(662):. PubMed ID: 33323410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the type-1 interferon receptor in APPSWE/PS1ΔE9 mice preserves cognitive function and alters glial phenotype.
    Minter MR; Moore Z; Zhang M; Brody KM; Jones NC; Shultz SR; Taylor JM; Crack PJ
    Acta Neuropathol Commun; 2016 Jul; 4(1):72. PubMed ID: 27400725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer's Mouse Phenotypes.
    Haas LT; Salazar SV; Smith LM; Zhao HR; Cox TO; Herber CS; Degnan AP; Balakrishnan A; Macor JE; Albright CF; Strittmatter SM
    Cell Rep; 2017 Jul; 20(1):76-88. PubMed ID: 28683325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mGluR5 antagonism increases autophagy and prevents disease progression in the
    Abd-Elrahman KS; Hamilton A; Hutchinson SR; Liu F; Russell RC; Ferguson SSG
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
    Lindemann L; Porter RH; Scharf SH; Kuennecke B; Bruns A; von Kienlin M; Harrison AC; Paehler A; Funk C; Gloge A; Schneider M; Parrott NJ; Polonchuk L; Niederhauser U; Morairty SR; Kilduff TS; Vieira E; Kolczewski S; Wichmann J; Hartung T; Honer M; Borroni E; Moreau JL; Prinssen E; Spooren W; Wettstein JG; Jaeschke G
    J Pharmacol Exp Ther; 2015 Apr; 353(1):213-33. PubMed ID: 25665805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT; Kostylev MA; Strittmatter SM
    J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice.
    Frost JL; Liu B; Rahfeld JU; Kleinschmidt M; O'Nuallain B; Le KX; Lues I; Caldarone BJ; Schilling S; Demuth HU; Lemere CA
    Neurobiol Aging; 2015 Dec; 36(12):3187-3199. PubMed ID: 26453001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traumatic brain injury accelerates amyloid-β deposition and impairs spatial learning in the triple-transgenic mouse model of Alzheimer's disease.
    Shishido H; Kishimoto Y; Kawai N; Toyota Y; Ueno M; Kubota T; Kirino Y; Tamiya T
    Neurosci Lett; 2016 Aug; 629():62-67. PubMed ID: 27373531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An App knock-in mouse inducing the formation of a toxic conformer of Aβ as a model for evaluating only oligomer-induced cognitive decline in Alzheimer's disease.
    Izuo N; Murakami K; Fujihara Y; Maeda M; Saito T; Saido TC; Irie K; Shimizu T
    Biochem Biophys Res Commun; 2019 Jul; 515(3):462-467. PubMed ID: 31164199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A positive allosteric modulator of mGluR5 promotes neuroprotective effects in mouse models of Alzheimer's disease.
    Bellozi PMQ; Gomes GF; da Silva MCM; Lima IVA; Batista CRÁ; Carneiro Junior WO; Dória JG; Vieira ÉLM; Vieira RP; de Freitas RP; Ferreira CN; Candelario-Jalil E; Wyss-Coray T; Ribeiro FM; de Oliveira ACP
    Neuropharmacology; 2019 Dec; 160():107785. PubMed ID: 31541651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
    Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
    Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-amyloid and ATP-induced diffusional trapping of astrocyte and neuronal metabotropic glutamate type-5 receptors.
    Shrivastava AN; Kowalewski JM; Renner M; Bousset L; Koulakoff A; Melki R; Giaume C; Triller A
    Glia; 2013 Oct; 61(10):1673-86. PubMed ID: 23922225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: Longitudinal studies.
    Zhang D; Qi Y; Klyubin I; Ondrejcak T; Sarell CJ; Cuello AC; Collinge J; Rowan MJ
    Neuropharmacology; 2017 Jul; 121():231-246. PubMed ID: 28390893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.
    Youssef EA; Berry-Kravis E; Czech C; Hagerman RJ; Hessl D; Wong CY; Rabbia M; Deptula D; John A; Kinch R; Drewitt P; Lindemann L; Marcinowski M; Langland R; Horn C; Fontoura P; Santarelli L; Quiroz JA;
    Neuropsychopharmacology; 2018 Feb; 43(3):503-512. PubMed ID: 28816242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.